IMMUNE DESIGN CORP's ticker is and the CUSIP is 45252L903. A total of 1 filers reported holding IMMUNE DESIGN CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | -98.2% | 200 | -98.7% | 0.00% | – |
| Q3 2018 | $55,000 | -49.5% | 15,900 | -33.5% | 0.00% | -100.0% |
| Q2 2018 | $109,000 | +2625.0% | 23,900 | +1891.7% | 0.00% | – |
| Q1 2018 | $4,000 | -20.0% | 1,200 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | -93.8% | 1,200 | -89.7% | 0.00% | -100.0% |
| Q1 2017 | $80,000 | +1042.9% | 11,700 | +875.0% | 0.00% | – |
| Q4 2016 | $7,000 | +16.7% | 1,200 | +300.0% | 0.00% | – |
| Q4 2015 | $6,000 | -75.0% | 300 | -85.0% | 0.00% | – |
| Q3 2015 | $24,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |